Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice

Cell Biology International

Volumn 31, Issue 5, 2007, Pages 500-507

  Dong, Ai Qiang ^a   Kong, Min Jian ^a   Ma, Zhi Yuan ^b   Qian, Jian Fang ^a   Xu, Xiao Hong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Lung cancer; RNA interference; Type I insulin like growth factor receptor

Indexed keywords

SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 34247167175     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.11.017     Document Type: Article

References (32)

1. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 6 (2002) 829-834
2. Beech D.J., Parekh N., and Pang Y. Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol. Oncol Rep 8 (2001) 325-329
3. Cantley L.C., Auger K.R., Carpenter C., Duckworth B., Graziani A., Kapeller R., et al. Oncogenes and signal transduction. Cell 64 (1991) 281-302
4. Chernicky C.L., Yi L., Tan H., Gan S.U., and Ilan J. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Cancer Gene Ther 7 (2000) 384-395
5. Donze O., and Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res 30 (2002) e46
6. Dunn S.E., Ehrlich M., Sharp N.J., Reiss K., Solomon G., Hawkins R., et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 58 (1998) 3353-3361
7. Evans T.L., and Lynch Jr. T.J. Lung Cancer. Oncologist 6 (2001) 407-414
8. Goetsch L., Gonzalez A., Leger O., Beck A., Pauwels P.J., Haeuw J.F., et al. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int J Cancer 113 (2005) 316-328
9. Greenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 50 (2000) 7-33
10. Hansen H.H. Treatment of advanced non-small cell lung cancer. BMJ 325 (2002) 452-453
11. Jiang Y., Rom W.N., Yie T.A., Chi C.X., and Tchou-Wong K.M. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene 18 (1999) 6071-6077
12. Kulik G., Klippel A., and Weber M.J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol. 17 (1997) 1595-1606
13. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
14. Macauly V.M., Teale J.D., Everard M.J., Joshi G.P., Smith I.E., and Millar J.L. Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer. Br J Cancer 57 (1988) 91-93
15. Maloney E.K., McLaughlin J.L., Dagdigian N.E., Garrett L.M., Connors K.M., Zhou X.M., et al. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63 (2003) 5073-5083
16. Mansour S.J., Matten W.T., Hermann A.S., Candia J.M., Rong S., Fukasawa K., et al. Transformation of mammalian cells by constitutively active MAP kinase. Science 265 (1994) 966-970
17. Miyagishi M., and Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20 (2002) 497-500
18. Nagy P., Arndt-Jovin D.J., and Jovin T.M. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp Cell Res 285 (2003) 39-49
19. Nakanishi Y., Mulshine J.L., Kasprzyk P.G., Natale R.B., Maneckjee R., Avis I., et al. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82 (1988) 354-359
20. Novina C.D., and Sharp P.A. The RNAi revolution. Nature 430 (2004) 161-164
21. Rochester M.A., Riedemann J., Hellawell G.O., Brewster S.F., and Macaulay V.M. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Therapy 12 (2005) 90-100
22. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci 13 (1988) 443-447
23. Singh P. Insulin-like growth factor system in growth, development and carcinogenesis. J Clin Lig Assay 23 (2000) 214-232
24. Toloza E.M. Gene therapy for lung cancer. Semin Thorac Cardiovasc Surg 17 (2005) 205-212
25. Toloza E.M., and D'Amico T.A. Targeted therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 17 (2005) 199-204
26. Troppmair J., Bruder J.T., Munoz H., Lloyd P.A., Kyriakis J., Banerjee P., et al. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 9 (1994) 7030-7035
27. Uprichard S.L. The therapeutic potential of RNA interference. FEBS Lett 579 (2005) 5996-6007
28. Williams L.T. Signal transduction by the platelet-derived growth factor receptor. Science 243 (1989) 1564-1570
29. Wu Y., Tewari M., Cui S., and Rubin R. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 168 (1996) 499-509
30. Yarden Y., and Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26 (1987) 1443-1451
31. Yarden Y., and Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 57 (1988) 443-478
32. Zamore P.D. RNA interference: listening to the sound of silence. Nat Struct Biol 8 (2001) 746-750